Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 0.67 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | XPO1 | O14980 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | BACE1 | P56817 | 3/20 | 0.52 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.52 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 3/20 | 0.52 |
| ▸ | NDUFS8 | O00217 | 1/20 | 0.51 |
| ▸ | COXFA4 | O00483 | 1/20 | 0.51 |
| ▸ | NDUFAB1 | O14561 | 1/20 | 0.51 |
| ▸ | NDUFA1 | O15239 | 1/20 | 0.51 |
| ▸ | NDUFS4 | O43181 | 1/20 | 0.51 |
| ▸ | NDUFB5 | O43674 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13532216 | 1.00 | PDE4D (0.67) | PDE4DABCB1ALOX5CYP3A4XPO1 | |
| SCHEMBL30379956 | 0.90 | PDE4D (0.81) | PDE4DABCB1ALOX5CYP3A4XPO1 | |
| SCHEMBL16341040 | 0.81 | PDE4D (1.00) | PDE4DABCB1ALOX5CYP3A4XPO1 | |
| SCHEMBL30158338 | 0.76 | MAOA (0.78) | ABCB1ALOX5CYP3A4XPO1ALDH1A1 | |
| SCHEMBL24075636 | 0.76 | MAOA (0.78) | ABCB1ALOX5CYP3A4XPO1ALDH1A1 | |
| SCHEMBL13532215 | 0.76 | BACE1 (0.57) | PDE4DABCB1ALOX5CYP3A4ALDH1A1 | |
| SCHEMBL28699738 | 0.73 | MAOB (0.62) | ALOX5PTGS2BCHEPPARGPTGES | |
| SCHEMBL27442812 | 0.72 | VKORC1 (0.67) | ALOX5BCHEPPARGPTGESMAOA | |
| SCHEMBL24075603 | 0.71 | KDM4E (0.78) | PDE4DABCB1ALOX5CYP3A4XPO1 | |
| Mulberrofuran B SCHEMBL31237319 | 0.71 | BACE1 (0.68) | ABCB1ALOX5CYP3A4XPO1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016419-A1 | ANTIBACTERIAL COMPOSITION | TAKEUCHI RYO | 2010-01-21 | — | — | US | claimed |
| EP-1788878-B1 | ANTIBACTERIAL COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2008-10-15 | — | — | EP | claimed |
| US-20080096958-A1 | Antibacterial Composition | TAKEUCHI RYO | 2008-04-24 | — | — | US | claimed |
| US-20100016419-A1 | ANTIBACTERIAL COMPOSITION | TAKEUCHI RYO | 2010-01-21 | — | — | US | disclosed |
| US-20100016419-A1 | ANTIBACTERIAL COMPOSITION | TAKEUCHI RYO | 2010-01-21 | — | — | US | disclosed |
| EP-1788878-B1 | ANTIBACTERIAL COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2008-10-15 | — | — | EP | disclosed |
| EP-1788878-B1 | ANTIBACTERIAL COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2008-10-15 | — | — | EP | disclosed |
| US-20080096958-A1 | Antibacterial Composition | TAKEUCHI RYO | 2008-04-24 | — | — | US | disclosed |
| CN-101022732-A | Antibacterial composition | TAKASAGO PERFUMERY CO LTD (JP) | 2007-08-22 | — | — | CN | disclosed |
| EP-1788878-A1 | ANTIBACTERIAL COMPOSITION | Takasago International Corporation (JP) | 2007-05-30 | — | — | EP | disclosed |
| EP-1788878-A1 | ANTIBACTERIAL COMPOSITION | Takasago International Corporation (JP) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006028025-A1 | ANTIBACTERIAL COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006028025-A1 | ANTIBACTERIAL COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096958-A1 | Antibacterial Composition | SPOUT1, NOP2, CASP7 | PDE4D 3995/4885ABCB1 587/4885ALOX5 1302/4885 |
| US-20100016419-A1 | ANTIBACTERIAL COMPOSITION | SPOUT1, CASP7, NOP2 | PDE4D 3988/4885ABCB1 624/4885ALOX5 1296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.